ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

292
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Refresh
05 Oct 2016 05:19

Samsung BioLogics IPO Part 2 - Financials

Samsung BioLogics has just filed an IPO report. I will summarize Samsung BioLogics IPO report in the following three parts:Part 1 - IPO...

Logo
133 Views
Share
04 Oct 2016 23:11

Samsung BioLogics IPO Part 1 - IPO Proceeding

Samsung BioLogics has just filed an IPO report. I will summarize Samsung BioLogics IPO report in the following three parts:Part 1 - IPO...

Logo
213 Views
Share
04 Oct 2016 07:43

Samsung BioLogics IPO Price, Capital Investment Plan & Valuation Issue

In a regulatory filing (last Friday), Samsung Biologics announced its plan to raise ₩1.23tril (US$1.12bil) of new shares. Samsung BioLogics plans...

Logo
269 Views
Share
bearishCelltrion Inc
16 Sep 2016 06:18

More Harsh Reality from Teva

U.S. healthcare industry leaders from across the spectrum of industry segments continue to downplay the near-term adoption of biosimilars in the...

Share
20 Aug 2016 22:28

US$9 Billion Valuation Is Rarefied Air

Samsung's proposed ~US$9 billion valuation for Samsung BioLogics would out the latter in a very select company: a US$9 billion market cap for a...

Share
x